ÂÜÀòÂÒÂ×

Graeme Pullen is an experienced professional in research and development, product innovation, and business development within the healthcare and enzyme technology sectors. Currently serving as the Director of the R&D Innovation Management Office at Hollister Incorporated since October 2018 and as the New Product Development Manager at Dansac A/S since August 2016, Graeme has a robust background that includes roles such as Principal Business Development Manager at LEO Pharma A/S and Business Development Manager at Novozymes, where the focus was on developing new business opportunities for enzyme applications. Graeme's previous positions cover significant roles at Coloplast, including Vice President of Ostomy Care Global R&D and various managerial positions in R&D and product management. Graeme holds a PhD in chemistry from The Manchester Metropolitan University and has completed a program on Management of Medical Product Innovation from the Scandinavian International Management Institute.